» Articles » PMID: 26561917

A Meta-analysis Comparing ProCore and Standard Fine-needle Aspiration Needles for Endoscopic Ultrasound-guided Tissue Acquisition

Overview
Journal Endoscopy
Date 2015 Nov 13
PMID 26561917
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Study Aims: To overcome the limitations associated with cytology, a uniquely designed needle (ProCore) was introduced in an effort to obtain a core of tissue under endoscopic ultrasound (EUS) guidance. However, studies comparing the sample quality between ProCore and standard-design fine-needle aspiration (FNA) needles have yielded varying results. A systematic review and meta-analysis was therefore conducted to compare the performance of the ProCore and standard FNA needles when performing EUS-guided tissue acquisition.

Patients And Methods: MEDLINE and EMBASE were searched to identify all published manuscripts that compared the ProCore needle with standard FNA needles. Noncomparative and technical feasibility studies were excluded. The main outcome measures were diagnostic adequacy, diagnostic accuracy, acquisition of histological core tissue, and mean number of passes required to achieve a diagnosis when sampling solid lesions.

Results: Nine studies (total 576 patients) met the inclusion criteria. There was no significant difference in diagnostic adequacy (75.2 % vs. 89.0 %, odds ratio [OR] 0.39, P = 0.23), diagnostic accuracy (85.8 % vs. 86.2 %, OR 0.88, P = 0.53) or rate of histological core specimen acquisition (77.7 % vs. 76.5 %, OR 0.94, P = 0.85) between the ProCore and standard FNA needles, respectively. The mean number of passes required for diagnosis, however, was significantly lower when using the ProCore needle (standardized mean difference - 1.2, P < 0.001).

Conclusions: Current data do not demonstrate a significant difference between the ProCore and standard FNA needles for sample adequacy, diagnostic accuracy or acquisition of a core specimen. However, the ProCore needle establishes the diagnosis with fewer passes.

Citing Articles

EUS FNAC without rapid on-site evaluation is comparable to EUS FNB with macroscopic on-site evaluation in evaluation of intra-abdominal masses.

Najar M, Jain M, Lamba G, Bopanna S Indian J Gastroenterol. 2025; .

PMID: 39969684 DOI: 10.1007/s12664-025-01741-3.


Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care.

Zhang W, Chen J, Zhang W, Xu M Biomedicines. 2025; 13(1).

PMID: 39857661 PMC: 11762820. DOI: 10.3390/biomedicines13010076.


Endoscopic Ultrasound-Guided Pancreatic Tissue Sampling: Lesion Assessment, Needles, and Techniques.

Dhar J, Samanta J, Nabi Z, Aggarwal M, Conti Bellocchi M, Facciorusso A Medicina (Kaunas). 2025; 60(12.

PMID: 39768901 PMC: 11727853. DOI: 10.3390/medicina60122021.


Comparing needle types and aspiration techniques in EUS-TA to optimize diagnostic efficacy and specimen quality in patients with pancreatic lesions.

Shang R, Han X, He F, Huang L, Zeng C, Chen K Front Med (Lausanne). 2024; 11:1422600.

PMID: 39712178 PMC: 11658985. DOI: 10.3389/fmed.2024.1422600.


Strategic insights into the cultivation of pancreatic cancer organoids from endoscopic ultrasonography-guided biopsy tissue.

Yang J, Zhang J, Gu J, Gao M, Zheng M, Guo S World J Gastroenterol. 2024; 30(42):4532-4543.

PMID: 39563744 PMC: 11572629. DOI: 10.3748/wjg.v30.i42.4532.